When is the first trough level for vancomycin (Vancomycin hydrochloride)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The first trough level for vancomycin should be drawn just before the fourth dose in most patients with normal renal function. This timing allows the medication to reach steady state, which typically occurs after 3-4 half-lives. For vancomycin, the half-life is approximately 6-8 hours in patients with normal kidney function 1. The blood sample should be collected 30 minutes before administering the next dose to ensure it represents the true trough concentration. If a patient has renal impairment, the timing may need to be adjusted as vancomycin clearance is primarily renal, and the drug may take longer to reach steady state in these patients. Accurate trough measurements are essential for therapeutic drug monitoring because they help ensure that vancomycin concentrations remain within the therapeutic range (typically 10-20 mcg/mL, with higher targets for serious infections like MRSA pneumonia or endocarditis), minimizing both treatment failure from underdosing and toxicity risks from overdosing, particularly nephrotoxicity. Some key points to consider when monitoring vancomycin trough levels include:

  • Trough vancomycin concentrations are the most accurate and practical method to guide vancomycin dosing 1
  • Serum trough concentrations should be obtained at steady state conditions, prior to the fourth or fifth dose 1
  • Monitoring of peak vancomycin concentrations is not recommended 1
  • The timing of trough level collection may need to be adjusted in patients with renal impairment 1

From the FDA Drug Label

In subjects with normal kidney function, multiple intravenous dosing of 1 g of vancomycin (15 mg/kg) infused over 60 minutes produces mean plasma concentrations of approximately 63 mcg/mL immediately after the completion of infusion, mean plasma concentrations of approximately 23 mcg/mL 2 hours after infusion, and mean plasma concentrations of approximately 8 mcg/mL 11 hours after the end of the infusion.

The first trough for vancomycin is not explicitly stated in the provided text, but based on the information given, it can be inferred that the trough concentration would be the lowest concentration before the next dose.

  • The concentration 11 hours after the end of the infusion is approximately 8 mcg/mL, but this is not necessarily the trough, as the trough is typically measured immediately before the next dose.
  • Since the dosing interval is not specified, the exact timing of the first trough cannot be determined from the provided information 2.

From the Research

Vancomycin Trough Levels

  • The first trough for vancomycin is typically drawn within 15 to 45 minutes before the fourth vancomycin dose 3.
  • Target trough levels of 15-20 microg/ml are proposed for vancomycin treatment 4.
  • Vancomycin trough concentrations are the most accurate and practical method for monitoring vancomycin effectiveness and risk of nephrotoxicity 3.

Factors Influencing Vancomycin Trough Levels

  • Age, gender, site of infection, and type of admission can significantly influence vancomycin trough levels 3, 5.
  • Higher vancomycin doses and trough levels, as well as increased vancomycin frequency and duration, are associated with significant increases in blood urea and serum creatinine levels 5.
  • Concomitant use of renal hypoperfusion medications, such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, loop diuretics, and non-steroidal anti-inflammatory drugs, can increase the risk of vancomycin nephrotoxicity 6.

Nephrotoxicity Risk

  • Higher initial and maximum trough levels are significantly linked to the development of acute kidney injury (AKI) 7.
  • A cut-off of 15 mg/L can detect AKI with a sensitivity of 62.6% and a specificity of 65.5%, while a 20 mg/L threshold results in a sensitivity of 42.9% and a specificity of 82.5% 7.
  • Increasing trough levels correlate with a significant rise in nephrotoxicity risk, and individualized pharmacokinetic tools may help minimize this risk 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.